Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Mankind Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543904NSE Symbol: MANKINDP/E(TTM):45.97
ISIN Demat:INE634S01028Div & Yield %:0EPS(TTM):45.51
Book Value(Rs):240.2139154Market Cap ( Cr.):83816.88Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 8127.157486.225523.184794.413829.063923.49
Excise Duty0.000.000.000.000.005.36
Net Sales8127.157486.225523.184794.413829.063918.13
Other Income 162.78203.81154.5093.8564.33209.08
Stock Adjustments -267.89365.27254.2544.51-22.08-77.25
Total Income8022.048055.305931.934932.773871.314049.96
EXPENDITURE :      
Raw Materials 2576.872886.712036.421617.421370.371353.52
Power & Fuel Cost62.0060.3647.1646.4935.0721.57
Employee Cost 1701.381462.761167.42991.47785.02798.01
Other Manufacturing Expenses 113.6293.5756.7157.7384.2642.35
Selling and Administration Expenses 1539.071378.52905.53696.80750.99772.41
Miscellaneous Expenses 168.47131.08192.07185.0676.3175.47
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure6161.406013.004405.313594.983102.023063.33
Operating Profit1860.652042.301526.621337.79769.30986.64
Interest 28.2347.548.2311.1039.6117.94
Gross Profit1832.421994.761518.391326.69729.69968.70
Depreciation269.58123.3378.1961.7738.3927.73
Profit Before Tax1562.841871.431440.201264.92691.30940.97
Tax291.64429.03346.99341.81187.46256.70
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax22.9452.988.84-35.11-10.20-10.09
Reported Net Profit1248.261389.421084.37958.23514.04694.36
Extraordinary Items 29.2962.0730.0918.58-0.230.00
Adjusted Net Profit1218.971327.351054.28939.65514.27694.36
Adjst. below Net Profit -4.86-0.79-1.56-69.15-1.64-0.08
P & L Balance brought forward6624.905236.273747.133160.502677.032318.77
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.000.00302.4428.93336.02
P & L Balance carried down7868.306624.904829.953747.133160.502677.03
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.00755.000.000.00
Earnings Per Share-Unit Curr31.1634.6827.0723.9212.8317.33
Earnings Per Share(Adj)-Unit CurrNANANANANANA
Book Value-Unit Curr194.31163.27118.1891.1576.5174.81